Re: Amended and Restated Employment Offer LetterParticipation Agreement • March 6th, 2024 • Boundless Bio, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2024 Company Industry JurisdictionYou are currently a party to an amended and restated employment offer letter with Boundless Bio, Inc. (the “Company”) dated January 1, 2020 (the “Prior Agreement”). You and the Company hereby agree to amend and restate the Prior Agreement to memorialize the terms of your continued employment with the Company, as provided in this amended and restated employment letter agreement (this “Amended Agreement”), effective as of the date on which the Company consummates its initial public offering (“IPO”). In the event the IPO does not occur, this Amended Agreement shall not become effective and the Prior Agreement shall continue in full force and effect.
Re: Amended and Restated Employment Offer LetterParticipation Agreement • March 6th, 2024 • Boundless Bio, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2024 Company Industry JurisdictionYou are currently a party to an employment offer letter with Boundless Bio, Inc. (the “Company”) dated June 23, 2021 (the “Prior Agreement”). You and the Company hereby agree to amend and restate the Prior Agreement to memorialize the terms of your continued employment with the Company, as provided in this amended and restated employment letter agreement (this “Amended Agreement”), effective as of the date on which the Company consummates its initial public offering (“IPO”). In the event the IPO does not occur, this Amended Agreement shall not become effective and the Prior Agreement shall continue in full force and effect.
Re: Amended and Restated Employment Offer LetterParticipation Agreement • March 6th, 2024 • Boundless Bio, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2024 Company Industry JurisdictionYou are currently a party to an employment offer letter with Boundless Bio, Inc. (the “Company”) dated December 3, 2021 (the “Prior Agreement”). You and the Company hereby agree to amend and restate the Prior Agreement to memorialize the terms of your continued employment with the Company, as provided in this amended and restated employment letter agreement (this “Amended Agreement”), effective as of the date on which the Company consummates its initial public offering (“IPO”). In the event the IPO does not occur, this Amended Agreement shall not become effective and the Prior Agreement shall continue in full force and effect.
Re: Amended and Restated Employment Offer LetterParticipation Agreement • March 6th, 2024 • Boundless Bio, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2024 Company Industry JurisdictionYou are currently a party to an employment offer letter with Boundless Bio, Inc. (the “Company”) dated June 29, 2021 (the “Prior Agreement”). You and the Company hereby agree to amend and restate the Prior Agreement to memorialize the terms of your continued employment with the Company, as provided in this amended and restated employment letter agreement (this “Amended Agreement”), effective as of the date on which the Company consummates its initial public offering (“IPO”). In the event the IPO does not occur, this Amended Agreement shall not become effective and the Prior Agreement shall continue in full force and effect.
Re: Amended and Restated Employment Offer LetterParticipation Agreement • March 6th, 2024 • Boundless Bio, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2024 Company Industry JurisdictionYou are currently a party to an employment offer letter with Boundless Bio, Inc. (the “Company”) dated January 1, 2020 (the “Prior Agreement”). You and the Company hereby agree to amend and restate the Prior Agreement to memorialize the terms of your continued employment with the Company, as provided in this amended and restated employment letter agreement (this “Amended Agreement”), effective as of the date on which the Company consummates its initial public offering (“IPO”). In the event the IPO does not occur, this Amended Agreement shall not become effective and the Prior Agreement shall continue in full force and effect.